Health Canada drug identification number

DIN 02445727 — REVESTIVE 5 MG

REVESTIVE is a kit; powder for solution of Teduglutide marketed by TAKEDA CANADA INC. The full Teduglutide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02445727
Brand name
REVESTIVE
Active ingredient
Teduglutide
Strength
5 MG
Dosage form
KIT; POWDER FOR SOLUTION
Route
SUBCUTANEOUS
Manufacturer
TAKEDA CANADA INC
Health Canada status
MARKETED
Drug class
Glucagon-like peptide-2 (GLP-2) analog

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.